Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Universe Pharmaceuticals ( (UPC) ) has provided an announcement.
Universe Pharmaceuticals INC, a Ji’an-based producer and distributor of traditional Chinese medicine derivatives and other pharmaceutical products across 30 Chinese provinces, has detailed its business focus on elderly patients’ health and general well-being. The company also acts as a distributor for biomedical drugs, medical instruments and dietary supplements made by other pharmaceutical firms.
On February 11, 2026, Universe Pharmaceuticals announced that all conditions for implementing its dual-class share structure had been satisfied, with the structure set to take effect on the Nasdaq Capital Market on February 13, 2026. Following amended and restated corporate documents, the firm’s authorized capital now comprises 1.8 billion Class A ordinary shares and 200 million Class B ordinary shares, while the Class A shares will continue to trade under the ticker UPC and the same CUSIP, signaling a governance and capital-structure shift that may consolidate control while preserving market trading continuity.
The most recent analyst rating on (UPC) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Universe Pharmaceuticals stock, see the UPC Stock Forecast page.
Spark’s Take on UPC Stock
According to Spark, TipRanks’ AI Analyst, UPC is a Neutral.
The score is held back primarily by weak financial performance (multi-year revenue contraction, sustained losses, and negative operating/free cash flow), partially offset by a conservative balance sheet and improving 2025 margins/cash burn. Technicals provide a modest tailwind with price above key moving averages and neutral momentum indicators, while valuation is constrained by the negative P/E and lack of dividend yield.
To see Spark’s full report on UPC stock, click here.
More about Universe Pharmaceuticals
Universe Pharmaceuticals INC is a China-based pharmaceutical producer and distributor headquartered in Ji’an, Jiangxi, focusing on traditional Chinese medicine derivative products for the elderly. The company also distributes biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces and dietary supplements from third-party manufacturers across 30 provinces in China.
Average Trading Volume: 94,149
Technical Sentiment Signal: Sell
Current Market Cap: $2.24M
For an in-depth examination of UPC stock, go to TipRanks’ Overview page.